Budesonide for the Induction and Maintenance of Remission in Crohn’s Disease: Systematic Review and Meta-Analysis for the Cochrane Collaboration

BACKGROUND: Budesonide is an oral glucocorticoid designed for the treatment of inflammatory bowel disease (IBD) that may reduce systemic adverse events (AEs). This review examined the efficacy and safety of budesonide for the induction and maintenance of clinical remission in Crohn’s disease (CD). M...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuenzig, M Ellen, Rezaie, Ali, Kaplan, Gilaad G, Otley, Anthony R, Steinhart, A Hillary, Griffiths, Anne Marie, Benchimol, Eric I, Seow, Cynthia H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328928/
https://www.ncbi.nlm.nih.gov/pubmed/30656288
http://dx.doi.org/10.1093/jcag/gwy018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328928/
https://www.ncbi.nlm.nih.gov/pubmed/30656288
http://dx.doi.org/10.1093/jcag/gwy018

Ejemplares similares